Skip to Content
From Hospital-Level to Patient-Level Antibiotic Consumption Data: How Can We Improve Surveillance of AntibioticUse in the Frame of Antibiotic StewardshipProgrammes?
PhD Thesis Graduate School for Health Sciences University of Bern.
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators
Journal of Antimicrobial Chemotherapy, 2023;, dkad235, https://doi.org/10.1093/jac/dkad235
Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019
Euro Surveill. 2023;28(20):pii=2200532. https://doi.org/10.2807/1560-7917.ES.2023.28.20.2200532
Bacterial species and antimicrobial resistance differ between catheter and non–catheter-associated urinary tract infections: Data from a national surveillance network
Antimicrobial Stewardship & Healthcare Epidemiology, 3(1), E55. doi:10.1017/ash.2022.340.
Increase in methicillin-susceptible
Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008–2021)
Infection (2023). https://doi.org/10.1007/s15010-023-01980-6.
Antibiotic resistance surveillance of
Klebsiella pneumoniae complex is affected by refined MALDI-TOF identification, Swiss data, 2017 to 2022.
Euro Surveill. 2022 Nov;27(45). doi: 10.2807/1560-7917.ES.2022.27.45.2200104. PMID: 36367012.
Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
Environ Res. 2022 Dec;215(Pt 2):114146. doi: 10.1016/j.envres.2022.114146. Epub 2022 Aug 19. PMID: 35988828.
Retrospective data analysis for definition of multidrug resistance in gram-negative bacteria – a consensus proposal.
Swiss Med Wkly. 2022 Jul 11;152:w30195. doi: 10.4414/smw.2022.w30195. PMID: 35816628.
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland
Antibiotics 2022, 11, 792. https://doi.org/10.3390/antibiotics 11060792.
Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals
J Hosp Infect. 120 (2022), p 36-42. PMID: 34798172.
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018.
Euro Surveill. 2021 Nov;26(46). PMID: 34794535.
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.
Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z. PMID: 34809698.
The consumption of anti-MRSA antibiotics in Swiss hospitals is associated with antibiotic stewardship measures
Journal of Hospital Infection 117 (2021) 165-171
Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland
Clin Microbiol Infect. 2021 Apr 30:S1198-743X(21)00212-3.
Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
Euro Surveill. 2020;26(15):pii=1900760. https://doi.org/10.2807/1560-7917. ES.2021.26.15.1900760
Echtzeit-Resistenzstatistik. Bekämpfung von Antibiotikaresistenzen in der Schweiz.
Vermeidung einer Pandemie mit multiresistenten Mikroorganismen: Lehren aus COVID-19?
Rapid Increase of CTX-M-Producing Shigella sonnei Isolates in Switzerland Due to Spread of Common Plasmids and International Clones
Antimicrob Agents Chemother. 2020 Sep 21;64(10):e01057-20. doi: 10.1128/AAC.01057-20. PMID: 32718957; PMCID: PMC7508577.
Treatment of urinary tract infections in Swiss primary care: quality and determinants of antibiotic prescribing
Increasing proportion of vancomycin resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.
Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland.
Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review.
Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data for a national surveillance network over an 8-year period (2009 – 2016).
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland
Catheter-related infections: does the spectrum of microbial causes change over time? A nationwide surveillance study.
Aktuelle Entwicklung der Antibiotikaresistenzen in der Schweiz.
Epidemiology of Subsequent Bloodstream Infections in the ICU.
Antibiotic resistance in Swiss nursing homes: analysis of National Surveillannce Data over an 11-year pertiod between 2007 and 2017.
Intrahospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae.
Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.
Low incidence of subsequent bateraemia or fungaemia after removal of a colonized intravascular catheter tip.
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide surveillance system.
Different Epidemiology of Hospital-Acquired Bloodstream Infections Between Small Community Hospitals and Large Community Hospitals.
Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzeralnd 2008-2014.
Patterns and Trends of Pediatric Bloodstream Infections. A 7-Year Surveillance Study.
Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014.
National Bloodstream Infecion Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals.
Improvement of Antibiotic Prescription in Outpatient Care: A Cluster-Randomized Intervention Study Using a Sentinel Surveillance Network of Physicians.
A Prospective Multicenter SPOG 2003 FN Study of Microbiologically Defined Infections in Pediatric Cancer Patients with Fever and Neutropenia.
Joint report 2013 ARCH-vet anresis.ch. Usage of Antibiotics and Occurence of Antibiotic Resistance in Bacteria from Humans and Animals in Switzerland.
November 2016. FOPH publication number: 2016-OEG-30.
Temporal trends of extended-spectrum cephalosporin resistant Escherichia coli and Klebsiella pneumoniae in Switzerland.
Extended-Spectrum Cephalosporins-Resistant Escherichia coli in Community, Specialized Outpatient Clinics, and Hospital Settings in Switzerland.
Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
International Journal of Antimicrobial Agents 41 (2013): 236– 249.
Swiss Medical Forum 2012;12(42):805-807.
Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Antimicrob Agents Chemother. 2012 Feb;56(2):989-94.
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.
J Hosp Infect. 2011 Oct;79(2):166-71.
Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests.
Clin Microbiol Infect. 2011 Jun;17(6):855-61.
Antibiotikaresistenzdaten der Schweiz: jetzt online.
Schweiz Med Forum 2008;8(22):415–418.
Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.
J. Clin. Microbiol 2006. 44:2032-8.
Back to top